Apollon Wealth Management, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 27 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
Apollon Wealth Management, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2022$101,000
+9.8%
17,900
+12.6%
0.01%0.0%
Q2 2022$92,000
-34.8%
15,900
+14.4%
0.01%
-20.0%
Q1 2022$141,000
-25.8%
13,900
-39.3%
0.01%
-28.6%
Q4 2021$190,000
+21.0%
22,900
+18.0%
0.01%
-36.4%
Q3 2021$157,00019,4000.02%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 1,198,000$6,733,0007.35%
K.J. Harrison & Partners Inc 479,838$2,748,0000.97%
SABBY MANAGEMENT, LLC 94,005$528,0000.67%
Redmond Asset Management, LLC 137,689$774,0000.29%
Concord Wealth Partners 17,775$100,0000.03%
Virtu Financial LLC 48,347$272,0000.02%
Caption Management, LLC 177,000$996,0000.01%
WASATCH ADVISORS LP 353,744$1,988,0000.01%
Summit Trail Advisors, LLC 35,000$197,0000.01%
BLUEFIN CAPITAL MANAGEMENT, LLC 17,546$99,0000.01%
View complete list of BRIACELL THERAPEUTICS CORP shareholders